Home
Download iQueue Application
CME Activities
Community
About iQueue
Spacer
Iqueue_logo
More Than 450 Free CME Activities in
Over 50 Therapeutic Categories
Click here to install iQueue and
begin viewing these online CME activities
Install iQueue Application
Spacer
Activity Detail
Return to Online CME Activities
Vaccine Timeline: History of the Adolescent Vaccination Platform in the US

In this Vaccine Timeline educational activity, four experts in the area of adolescent immunization give an overview of the Advisory Committee on Immunization Practices-based U.S. immunization approach in the context of historical use of immunizations and where we are today.

Cmeact_item_seperator
CME Release Date

January 31, 2012

 
CME Expiration Date

January 31, 2013

 
Estimated Time to Complete Activity

1.0 Hour(s)

 
Medium

Internet

 
Target Audience

This activity has been designed to meet the educational needs of pediatricians, infectious disease specialists, primary care physicians and allied healthcare workers that treat children.

 
Program Overview

In this Vaccine Timeline educational activity, four experts in the area of adolescent immunization give an overview of the Advisory Committee on Immunization Practices-based U.S. immunization approach in the context of historical use of immunizations and where we are today. The key feature of the activity is a “timeline” that summarizes key events in the evolution of today’s adolescent immunization schedule as well as background information on vaccine-preventable illnesses. The timeline shows how immunization strategies have evolved to protect public health, particularly in the last century. An overview of the current schedule for children aged 7–18 years of age, including catch-up, is discussed. The activity includes a Q&A portion where the faculty members provide perspectives on current issues, such as parental concerns about vaccine safety and barriers to vaccinating adolescent patients.

 
Learning Objectives

Describe the role of the harmonized immunization schedule and identify the age ranges covered by each schedule, the frequency of updates, and the source for information on upcoming updates.

Describe the role of the “catch-up” schedule and the process for implementing catch-up of immunizations into patient wellness visits.

Identify the vaccines that should be given at the pivotal 11–12 year-old visit.

Name the adolescent patients who should receive the hepatitis A vaccine per the updates of 2007 and 2008.

Identify the adolescent patient populations who should receive the HPV vaccine and the frequency of vaccination.
 

 
Faculty

Elizabeth M. Alderman, MD
Professor of Clinical Pediatrics
Albert Einstein College of Medicine
Director, Post-Doctoral Fellowship Adolescent Medicine
Director, Adolescent Ambulatory Service
Children’s Hospital at Montefiore
Bronx, NY

Amanda F. Dempsey, MD, PhD, MPH
Associate Professor of Pediatrics
University of Colorado in Denver
Child Outcomes Research Group
Denver, CO

Amy B. Middleman, MD, MPH, MS Ed
Baylor College of Medicine
Clinical Physician, Pediatrics and Adolescent Medicine
Texas Children’s Hospital
Houston, TX

Joel Palefsky, MD, CM, FRCP(C)
Professor, Department of Medicine
Division of Infectious Disease
University of California San Francisco (UCSF)
Director, UCSF Anal Dysplasia Clinic
UCSF – Mt. Zion Medical Center
San Francisco, CA

Katherine Galluzzi, DO, CMD – Course Director
Professor and Chairperson
Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Staff Physician
Family Medicine
Roxborough Memorial Hospital
Philadelphia, PA
 

 
Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact Med Learning Group for privacy and confidentiality policy statement information at:

http://www.medlearninggroup.com/Privacy.aspx?id=3

Copyright:  © 2012 Med Learning Group

 
Credit Designation Statement

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
Method of Participation

There are no fees for participating and receiving CME credit for this activity. During the period January 31, 2012 through January 31, 2013, participants must:

Read the educational objectives and faculty disclosures.

Study all parts of the educational activity.

Complete the posttest by recording the best answer to each question in the answer key and complete the evaluation form.

Submit the evaluation form online.

To participate in this activity, please view the presentation and take the posttest. Fill in the answer sheet and evaluation form and submit online.  CME credit will be awarded if a score of 70% or better is achieved. You will receive your certificate instantly.

 
Disclosure Policy Statement

Med Learning Group requires all individuals involved in the development and presentation of continuing medical education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Med Learning Group has procedures to resolve apparent conflicts of interest. Faculty members are also requested to disclose when unapproved use of pharmaceuticals and devices are being discussed.

 
Disclosure of Conflicts of Interest

Elizabeth M. Alderman, MD has disclosed that she is on the Speakers’ Bureau for Merck & Co., Inc.

Amanda F. Dempsey, MD has disclosed that she is a consultant for Merck & Co., Inc.

Amy B. Middleman, MD, MPH, MS Ed has disclosed that she receives grant / research funding from CDC, MedImmune, Novartis and Sanofi Pasteur.  Dr. Middleman is also a consultant for CDC, MedImmune, Novartis and Sanofi Pasteur.

Joel Palefsky, MD, CM, FRCP(C) has disclosed that he receives grant / research funding from Aura Biosciences and Merck & Co., Inc.  Dr. Palefsky is also a consultant for Merck & Co., Inc. and PharmaJet Inc.

Katherine Galluzzi, DO, CMD, has nothing to disclose.


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Tara Hun-Dorris, MMC, ELS, of THD Editorial, Inc., has nothing to disclose.

Kelly Kraines of Med Learning Group has nothing to disclose.

Christopher Cahill of Med Learning Group has nothing to disclose.

 
Disclosure of Off-Label Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

 
Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes.

 
Hardware/Software Requirements

iQueue is accessible using the Adobe AIR and Adobe Reader software. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, or Microsoft PowerPoint.

 
Spacer
©2009 iQueueOnline. All rights reserved.  |   Terms of Use   |   Privacy Policy   |   Contact Us